FDAsafety guidance72% confidence
Guidance Documents for Rare Disease Drug Development
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Sound Pharmaceuticals.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Otolaryngology · Meniere's Disease
- Sub-indication
- General
Related signal: SPI-1005 Trial for Meniere's Disease Evaluates Safety and Efficacy